Literature DB >> 29204106

Morbidity dynamics in proton-photon or photon radiation therapy for locally advanced prostate cancer.

Evgeny V Khmelevsky1, Irina N Kancheli2, Vladimir S Khoroshkov2, Andrey D Kaprin1.   

Abstract

AIM: This study evaluated the frequency and long-term dynamics of early and late post irradiation damage after proton-photon or photon therapy for locally advanced prostate cancer.
BACKGROUND: The results of a randomized study of proton-photon or photon therapy using several fractionation regimes were analyzed in 272 patients with high and intermediate risk of progression.
MATERIALS AND METHODS: Three variants of proton boost fractionation were studied sequentially: 3.0 (8 daily fractions), 4.0 (5 fractions, 3 or 5 fractions/week), and 5.5 (3 fractions, 3 fractions/week) Gy(RBE).
RESULTS: A significant decrease in the severity of both acute and late gastrointestinal injuries is achievable with a proton beam. The dynamics of late gastrointestinal and genitourinary toxicity over a 10-year period were generally characterized by a decrease in severity of morbidity by 30% and 15%, respectively.
CONCLUSIONS: Local irradiation with a fractional dose of 3.0-5.5 Gy(RBE) and a cumulative dose of 28.0-28.8 Gy(RBE) for protons significantly reduces the early and late rectitis severity, but does not reduce the risk of lower urinary tract injuries. Fractionation regimens do not significantly differ in toxicity levels.

Entities:  

Keywords:  Hypofractionation; Prostate cancer; Protons; Radiation therapy; Toxicity

Year:  2017        PMID: 29204106      PMCID: PMC5709285          DOI: 10.1016/j.rpor.2017.11.001

Source DB:  PubMed          Journal:  Rep Pract Oncol Radiother        ISSN: 1507-1367


  16 in total

1.  Radical external beam radiotherapy for localised carcinoma of the prostate using a hypofractionation technique.

Authors:  C D Collins; R W Lloyd-Davies; A V Swan
Journal:  Clin Oncol (R Coll Radiol)       Date:  1991-05       Impact factor: 4.126

2.  Hypofractionated intensity-modulated radiotherapy (70 gy at 2.5 Gy per fraction) for localized prostate cancer: long-term outcomes.

Authors:  Patrick A Kupelian; Vipul V Thakkar; Deepak Khuntia; Chandana A Reddy; Eric A Klein; Arul Mahadevan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-09-19       Impact factor: 7.038

3.  Hypofractionated versus conventionally fractionated radiotherapy for prostate carcinoma: final results of phase III randomized trial.

Authors:  Eric E Yeoh; Rochelle J Botten; Julie Butters; Addolorata C Di Matteo; Richard H Holloway; Jack Fowler
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-10-08       Impact factor: 7.038

4.  Stereotactic hypofractionated accurate radiotherapy of the prostate (SHARP), 33.5 Gy in five fractions for localized disease: first clinical trial results.

Authors:  Berit L Madsen; R Alex Hsi; Huong T Pham; Jack F Fowler; Laura Esagui; John Corman
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-03-15       Impact factor: 7.038

5.  Dose-fractionation sensitivity of prostate cancer deduced from radiotherapy outcomes of 5,969 patients in seven international institutional datasets: α/β = 1.4 (0.9-2.2) Gy.

Authors:  Raymond Miralbell; Stephen A Roberts; Eduardo Zubizarreta; Jolyon H Hendry
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-02-15       Impact factor: 7.038

6.  Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group/american college of radiology 95-09.

Authors:  Anthony L Zietman; Kyounghwa Bae; Jerry D Slater; William U Shipley; Jason A Efstathiou; John J Coen; David A Bush; Margie Lunt; Daphna Y Spiegel; Rafi Skowronski; B Rodney Jabola; Carl J Rossi
Journal:  J Clin Oncol       Date:  2010-02-01       Impact factor: 44.544

7.  Outcomes in men with large prostates (≥ 60 cm(3)) treated with definitive proton therapy for prostate cancer.

Authors:  Lisa McGee; Nancy P Mendenhall; Randal H Henderson; Christopher G Morris; Romaine C Nichols; Robert J Marcus; Zuofeng Li; William M Mendenhall; Christopher R Williams; Bradford S Hoppe
Journal:  Acta Oncol       Date:  2012-12-17       Impact factor: 4.089

8.  External beam radiation therapy after transurethral resection of the prostate: a report on acute and late genitourinary toxicity.

Authors:  Kiran Devisetty; Kevin C Zorn; Mark H Katz; Ashesh B Jani; Stanley L Liauw
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-01-04       Impact factor: 7.038

9.  Proton therapy for prostate cancer treatment employing online image guidance and an action level threshold.

Authors:  Carlos Vargas; Aaron Falchook; Daniel Indelicato; Anamaria Yeung; Randall Henderson; Kenneth Olivier; Sameer Keole; Christopher Williams; Zuofeng Li; Jatinder Palta
Journal:  Am J Clin Oncol       Date:  2009-04       Impact factor: 2.339

10.  Hypofractionated proton boost combined with external beam radiotherapy for treatment of localized prostate cancer.

Authors:  Silvia Johansson; Lennart Aström; Fredrik Sandin; Ulf Isacsson; Anders Montelius; Ingela Turesson
Journal:  Prostate Cancer       Date:  2012-07-08
View more
  3 in total

Review 1.  The Role of Hypofractionation in Proton Therapy.

Authors:  Alexandre Santos; Scott Penfold; Peter Gorayski; Hien Le
Journal:  Cancers (Basel)       Date:  2022-05-02       Impact factor: 6.575

2.  The incidence of inflammation among patients suffering from cervix cancer with positive beta haemolytic streptococci cultures from genital tract.

Authors:  Zefiryn Cybulski; Bartosz Urbański; Alicja Grabiec; Zofia Talaga; Michał Pawlak; Żaneta Wareńczak-Florczak; Andrzej Roszak
Journal:  Rep Pract Oncol Radiother       Date:  2019-09-11

Review 3.  Proton Therapy in Head and Neck Cancer Treatment: State of the Problem and Development Prospects (Review).

Authors:  K B Gordon; D I Smyk; I A Gulidov
Journal:  Sovrem Tekhnologii Med       Date:  2021-08-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.